Beyond diabetes control and weight management, GLP-1s could have yet another benefit: helping with migraines.
In a small study, a GLP-1 drug shrank the number of days people spent with a migraine by almost half in a given month.
Presented at the European Academy of Neurology Congress in Helinski, Finland, on June 21, the results suggest promising future uses of the popular obesity and diabetes drugs.